Quote:
Originally Posted by Pugchief
You guys both completely missed my point. I have no idea what statement you think I made you are responding to.
Not sure what a typhoon has to do with anything, and no, there is no US manufacturing capacity to pick up the slack of prescription drugs manufactured in China.
I was trying to point out that supply chains from overseas, China in particular, were adversely affected by Covid, and nothing was done to improve that situation in the 3 years after. Which is a big failure in leadership IMO.
|
You want more production stateside in case of a hurricane. The NC facility *is* stateside which is precisely why it was affected by the hurricane. At that point I’m not sure what you want.
You ask what could possibly happen with the production coming from China. I suppose a typhoon could happen, just as a hurricane happened this time.
You are concerned about the volume coming from China. It turns out that volume is about 13% of us pharm imports. Not an insignificant volume but less than half of what is currently produced in the US.
A worldwide pandemic would likely affect production, well, worldwide. Not sure what mitigation you are looking for. 100% production in the US? Who will pay for that? What will happen then when a hurricane takes out a double digit percentage of production?
Possibly, just possibly, leadership has consulted knowledgeable advisors and has taken reasonable steps already.
Edit: Not to mention that we still run under a free market system and production is by private companies that make their own decision. Unless you are proposing that the govt. take over pharmaceutical production…